UNSPSC 51321606: Inositol hexanitrate

This classification denotes an intracellular second messenger with the molecular formula C6H6N6O18, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 686T63H73D, chemically known as inositol, hexanitrate, but more generally known as inositol hexanitrate, which bears US NIH Compound Identifier 23746. European Medicines Agency schedules inositol hexanitrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02688MIG.

Most nations, for tariff purposes, schedule inositol hexanitrate under HS 29061300. SMILES: [C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-].

UNSPSC 51321606 Inositol hexanitrate is a Commodity code covering specific pharmaceutical active pharmaceutical ingredients and finished medications supplied to state and local healthcare and emergency-response systems. State and local governments procure under this code primarily through emergency medical services departments, fire rescue agencies, public health departments, and cooperative purchasing alliances that source medications for paramedic protocols, hospital formularies, and state Medicaid pharmacy benefit programs. The work solicited includes supply of advanced life support medications, generic pharmaceuticals, and over-the-counter products with firm pricing, expiration-date warranties, rapid delivery turnaround, and compliance with FDA, cGMP, and Drug Supply Chain Security Act requirements. Issuing bodies range from municipal fire departments to state health agencies and multistate cooperative purchasing vehicles, with recent activity showing both small point-of-use procurements and statewide framework agreements.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department solicited sealed bids (26P00188, due April 8, 2026) for advanced life support medications including Labetalol, Epinephrine, Adenosine, and Diltiazem for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market 5 percent bid discount. The Texas Health and Human Services Commission issued a Request for Information (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription procurement models outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with awards effective July 1, 2026 and a two-year initial term.